Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 198 Posts
1 2 3 ... 13
Bristol-Meyers (BMY) Head And Shoulders Pattern
Article By: Gareth Soloway Thursday, January 30, 2020 12:46 PM EST
A head and shoulders pattern is a very bearish signal on a stock chart and usually signals a sharp move lower.
In this article: BMY
Read
Bristol-Myers Squibb: Strong Quality And Attractive Valuation
Article By: Andres Cardenal Tuesday, January 28, 2020 5:50 AM EST
Bristol-Myers Squibb has an outstanding track record of consistent revenue growth and superior profitability. The stock is very reasonably valued at current levels.
In this article: BMY Also: BMYMP
Read
This Is How You Can Beat The Market Without Fail
Video By: Chuck Carnevale Saturday, January 11, 2020 12:29 PM EST
The key to understanding and appreciating the relevance of focusing on dividend income performance over price performance is the recognition that dividends are paid on the number of shares you own.
In this video: MMM, BMY, CAT, CMI, OMC, PFG, PRU, RY, SPG, AVGO
Watch
The 5 Best Biotech Stocks To Buy In 2020
Article By: Money Morning Monday, January 6, 2020 6:17 AM EST
One of the sectors with higher risk and the highest reward is biotech. Over the last 10 years, the biotech sector has produced nearly 20% annualized gains. Here are our picks for 2020.
In this article: BMY, GSK, LGND, AMGN, BIIB
Read
In Search For Cheap Stocks With Improving Fundamentals
Article By: Andres Cardenal Friday, December 13, 2019 7:24 PM EST
Buying cheap stocks is great.... buying cheap stocks with improving fundamentals is better.
In this article: BMY, AMAT, ATKR Also: FNV, KNL, FTNT, INCY, FORM, ESNT, IBP
Read
Trade It: Bristol-Myers Squibb (BMY) Double Top
Article By: Gareth Soloway Thursday, December 12, 2019 1:08 PM EST
Shares of Bristol-Myers Squibb (BMY​) have surged 50% in the last 5 months.
In this article: BMY
Read
4 Big Drugmakers To Bet On After A Great Earnings Season
Article By: Zacks Investment Research Friday, November 15, 2019 8:35 AM EST
New drugs and label expansions of blockbuster drugs drove the top line of most of the big shots backed by higher demand, which countered headwinds from generic/biosimilar competition for older medicines.
In this article: BMY, GSK, MRK, NVO Also: JNJ, PFE, ABBV
Read
Bristol-Myers Squibb Posts Q3 Earnings Beat, Raises Full-Year Guidance
Article By: Benzinga Thursday, October 31, 2019 10:07 AM EST
Bristol-Myers Squibb reported third-quarter earnings of $1.17 per share Thursday, beating the analyst consensus estimate of $1.07.
In this article: BMY
Read
E No Memorial Today
Article By: Vivian Lewis Tuesday, October 22, 2019 11:55 PM EST
Our sold stocks are crashing and our bought stocks climbing! We have reports from the USA, Japan, Israel, Denmark, and Canada, and that's only about pharmaceuticals. We also have exciting news about lung cancer, but some bad news from India...
In this article: BMY, NVO, ESALY, GNCGY, NPSNY, BIIB, INFY, TEVA, ZYME, PROSY, EC, SLB, SQM, CMDXF, JMPLY, ITRN, LBTYA, LBTYK, CZZ, TMRAF, SAN, ANFGF, AZSEY, ACAT, CBBYF
Read
Back To The Negotiating Table
Article By: Mati Greenspan Tuesday, August 27, 2019 8:11 AM EST
The market focus going into last week was shifting from the US-China trade war to the Fed and the monetary policy of other central banks.
In this article: BITCOMP, DISH, BYND, BMY, WORK, LYFT
Read
Bristol-Myers Passes $74 Bln Deal’s First Big Exam
Article By: Lipper Alpha Insight Tuesday, August 27, 2019 4:24 AM EST
Bristol-Myers Squibb boss Giovanni Caforio can heave a sigh of relief. The drugmaker, valued at $76 billion at Friday’s close, is stretching to buy Celgene for almost as much again.
In this article: CELG, BMY
Read
Four High Earnings Yield Stocks To Bolster Your Portfolio
Article By: Zacks Investment Research Tuesday, August 20, 2019 10:59 AM EST
If you are not sure whether to invest your money in bonds or stocks, a key parameter that can show you the right direction is earnings yield.
In this article: BMY, CMC, DAL, UAL
Read
Bristol-Myers Squibb Is Undervalued
Article By: Andres Cardenal Monday, August 19, 2019 4:36 PM EST
Bristol-Myers Squibb is under considerable pressure, the stock has declined by more than 25% from its highs of the year due to generalized negativity towards the drug manufacturing sector and the uncertainty produced by the Celgene acquisition.
In this article: BMY Also: CELG
Read
Week In Review: How Trump's Policies Moved Stocks - July 28th, 2019
Article By: The Fly Sunday, July 28, 2019 7:47 PM EST
DOJ probes big tech as Trump says no to Apple request for tariff relief.
In this article: AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, WDC, RHHBY, AAPL, AMZN, AVGO, CSCO, GOOG, INTC, MU, QCOM, FB, GOOGL
Read
Bristol-Myers Squibb Q2 Earnings And Revenues Beat Estimates
Article By: Zacks Investment Research Thursday, July 25, 2019 10:13 AM EST
Bristol-Myers Squibb came out with quarterly earnings of $1.18 per share.
In this article: BMY
Read
Week In Review: How Trump's Policies Moved Stocks - July 21, 2019
Article By: The Fly Sunday, July 21, 2019 6:44 PM EST
Trump is looking into Pentagon's JEDI contract as US-China trade talks stall. The contract, set to be awarded to Amazon or Microsoft, is worth up to $10B. Plus Trump continues his pressure on the FED and some pharmaceutical news,
In this article: AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, AMZN, MSFT, ORCL
Read
1 to 16 of 198 Posts
1 2 3 ... 13